نيوزيمن:
2025-07-06@21:28:12 GMT

Sanaa.. A Houthi court acquits Al-Mutawakkil in the “lethal injection” case

تاريخ النشر: 26th, September 2023 GMT

On Sunday, September 24, 2023, a Houthi court acquitted the Houthi leader appointed to the position of Minister of Public Health and Population in the unrecognized government, Houthi leader Taha Al-Mutawakkil, of responsibility for the killing and wounding of 21 Yemeni children in the case of the fatal dose for cancer patients in Kuwait Hospital, last year.

The court contented itself with convicting the Supreme Pharmaceutical Authority on charges of providing assistance to the convicts (Faisal Muhammad Muhammad Awad, Fahd Abu Bakr Muhammad Salem, and Abdullah Rashid Ali Al-Ariqi), who were punished with one-year suspended imprisonment.

The ruling stipulated that the Medicines Authority be punished by “paying a fine of 10 million Yemeni riyals to the Children’s Leukemia Unit at Kuwait University Hospital, as well as obliging it to pay 10 million Yemeni riyals to receive the blood of a deceased child to each guardian, and to pay five million Yemeni riyals to each infected child, in compensation for the damages.” 

The West Amanah Court obligated the convicts to “pay an amount of 20 million riyals, which will be given to the guardians of injured children from the first to the tenth, and pay an amount of 11 million riyals, which will be given to the guardians of the blood of the victims, in exchange for fines and losses from litigation.”

The ruling implicitly acknowledged the responsibility of the Ministry of Health and its affiliated institutions, as the court approved “obliging the Ministry of Public Health and Population, the Supreme Authority for Medicines, the health offices in the governorates, and the Anti-Smuggling Unit in all ports of the Republic of Yemen, to bear their legal responsibilities, and to apply and implement legal legislation related to health and control of the pharmaceutical market.” “And to ensure the extent to which medical and pharmaceutical facilities comply with legal and health requirements or not.”

In an indication of the negligence and negligence of the officials of the Ministry of Public Health and Population in Sana’a, the court approved “obligating the Minister of Health and the National Center for the Treatment of Cancer Tumors to provide medical services for the treatment of tumors, develop the scientific and practical capabilities and competencies of the workers, and qualify them in the field of oncology treatment.”

The Yemeni Organization for Combating Human Trafficking said, after the crime occurred in September last year, that the Ministry of Public Health and Population affiliated with the Houthi militia dispensed an expired dose of treatment to children with cancer in Kuwait Hospital, which led to the poisoning and death of dozens of children.

Sources working in the health sector revealed to Newsyemen that pharmaceutical items classified as drugs had entered Sanaa and were smuggled from Kenya to Mogadishu and from Mogadishu to Yemen, through smugglers and those influential within the ranks of the group.

It indicated the involvement of leaders within the ranks of Iran's militia, in facilitating the entry of smuggled medicines into Yemen within days, in exchange for obstructing and delaying the agents' medicines for more than 3 months to transport them from Aden to Sana'a.

المصدر: نيوزيمن

إقرأ أيضاً:

EFG Hermes Successfully Completes Advisory on USD 500 Million IPO of Specialized Medical Company on the Saudi Exchange

 

EFG Hermes، an EFG Holding company and the leading investment bank in the Middle East and North Africa (MENA)،announced today that its investment banking division successfully completed its advisory on the USD 500 million initial public offering (IPO) of Specialized Medical Company(SMC)، one of the leading healthcare providers in the Kingdom of Saudi Arabia، on the Main Market of the Saudi Exchange(Tadawul). This marks EFG Hermes’ third IPO in the healthcare space in the past 12 months، further reinforcing its position as a trusted advisor across the region’s most dynamic sectors.

The company began trading today under the ticker 4019.

Specialized Medical Company offered a total of 30% of its total issued share capital through the sale of 75 million ordinary shares at SAR 25 per share، implying a market capitalization of SAR 6،250 million (USD 1،667 million). The orders recorded during the institutional book-building exceeded SAR 121.3 billion، representing a coverage of 64.7x.

Karim Meleka، Co-Head of Investment Banking at EFG Hermes، said، “We are proud to have advised on the IPO of Specialized Medical Company. Despite heightened geopolitical tensions in the region، the offering attracted overwhelming interest from a diverse base of local، regional، and international investors — a clear vote of confidence not only in SMC’s fundamentals but also in the resilience of Saudi Arabia’s capital markets and the strength of its macroeconomic outlook.”

SMC was founded in 1999 and is one of Riyadh’s leading multi-specialty private healthcare providers، with a 25-year track record of delivering high-quality، patient-centric medical care.The Company operates two state-of-the-art hospitals in Riyadhwith a combined capacity of 578 inpatient beds and 266 outpatient clinics. SMC is strategically expanding into Northern Riyadh، where rapid urban development is creating strong demand for healthcare services. With three additional hospitals، it is expected to capture over 25% of private hospital capacity in the area، establishing a leading position in an underpenetrated region with limited existing healthcare infrastructure – one that is set to become Riyadh’s new urban hub. Once operational، the new facilities are expected to more than double the Company’s current capacity to approximately 1،276 beds and 770 outpatient clinics.

EFG Hermes acted as a Joint Financial Advisor، Joint Bookrunner، and Joint Underwriter on the transaction.

EFG Hermes has advised on six IPOs across the region year to date، including landmark transactions on Tadawul، the Abu Dhabi Securities Exchange، the Muscat Stock Exchange، and the Egyptian Exchange، underscoring its regional leadership in equity capital markets.

- ENDS –

About EFG Holding

EFG Holding (EGX: HRHO.CA – LSE: EFGD) is a financial institution that boasts a remarkable 40-year legacy of success in seven countries spanning two continents. Operating within three distinct verticals — the Investment Bank (EFG Hermes)، Non-Bank Financial Institutions (NBFI) (EFG Finance)، and Commercial Bank (Bank NXT) — the company provides a comprehensive range of groundbreaking financial products and services tailored to meet the needs of a diverse clientele، including individual clients and businesses of all sizes.

 

EFG Hermes، the leading investment bank in the Middle East and North Africa (MENA)، offers extensive financial services، encompassing advisory، asset management، securities brokerage، research، and private equity. In its domestic market، EFG Holding serves as a universal bank، with EFG Finance emerging as the fastest-growing NBFI platform، comprising Tanmeyah،  a provider of innovative and integrated financial solutions for small business owners and entrepreneurs، EFG Corp-Solutions، which provides leasing and factoring services، Valu، a universal financial technology powerhouse، Bedaya for mortgage finance، Kaf for insurance، and EFG Finance SMEs، which provides financial services for small and medium enterprises. Furthermore، the company delivers commercial banking solutions through Bank NXT، an integrated retail and corporate banking product provider in Egypt. 

 

مقالات مشابهة

  • EFG Hermes Successfully Completes Advisory on USD 500 Million IPO of Specialized Medical Company on the Saudi Exchange